Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tranexamic acid for bleeding reduction during external dacryocystorhinostomy
IRCT20211121053138N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tranexamic acid in dacryostenosis (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Amount of bleeding. Started Dec 2021; status: completed.
02
Drugs
tranexamic acid
03
Conditions
dacryostenosis
Beyond the preview
Go deeper on IRCT20211121053138N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211121053138N1.